BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/2/2016 1:35:00 PM | Browse: 1361 | Download: 2628
 |
Received |
|
2015-04-23 17:13 |
 |
Peer-Review Started |
|
2015-04-24 16:53 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2015-07-13 19:06 |
 |
Revised |
|
2015-08-31 08:42 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2015-11-09 08:06 |
 |
Second Decision by Editor-in-Chief |
|
2015-11-10 22:14 |
 |
Final Decision by Editorial Office Director |
|
2015-12-01 08:04 |
 |
Articles in Press |
|
2015-12-01 08:04 |
 |
Edit the Manuscript by Language Editor |
|
2015-12-14 20:21 |
 |
Typeset the Manuscript |
|
2016-02-16 15:42 |
 |
Publish the Manuscript Online |
|
2016-03-02 13:35 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Inhibition of SW620 human colon cancer cells by upregulating miRNA-145
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Chen Li, Na Xu, Yu-Qiang Li, Yu Wang and Zhi-Tu Zhu |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Liaoning Medical “Principal Fund” special fund clinical construction |
XZJJ20130214 |
| Liaoning Provincial Science and Technology Department of Science and Technology Program |
2013225305 |
|
| Corresponding Author |
Zhi-Tu Zhu, MD, Department of Oncology, The First Affiliated Hospital of Liaoning Medical University, No. 2, Wuduan, Renmin Street, Jinzhou 121001, Liaoning Province, China. zhuzhitu2014jz@hotmail.com
|
| Key Words |
miRNA-145; Colorectal cancer; Targeted therapy; N-ras; Lentiviral vector |
| Core Tip |
miRNA-145 (miR-145) may play an important role in inhibiting colon cancer proliferation and invasive migration. This finding lays a good foundation for further investigation of targeting miR-145 as a tumor suppressor in colon cancer treatment, and provides novel evidence for the anti-cancer effects and therapeutic potential of miR-145.
|
| Publish Date |
2016-03-02 13:35 |
| Citation |
Li C, Xu N, Li YQ, Wang Y, Zhu ZT. Inhibition of SW620 human colon cancer cells by upregulating miRNA-145. World J Gastroenterol 2016; 22(9): 2771-2778 |
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i9/2771.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i9.2771 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.